[PLX] QoQ Quarter Result on 31-Mar-2024 [#Q1]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
10-May-2024
Financial Year
2024
Quarter
31-Mar-2024 [#Q1]
Profit Trend
QoQ- 23.97%
YoY- -46.76%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 13,474 3,748 10,486 10,345 35,075 9,588 8,617 34.75%
PBT -2,272 -4,733 -6,426 -1,719 19,647 -2,936 -3,210 -20.59%
Tax -69 -138 -382 133 308 195 530 -
NP -2,203 -4,595 -6,044 -1,852 19,339 -3,131 -3,740 -29.75%
Tax Rate - - - - -1.57% - - -
Total Cost 15,677 8,343 16,530 12,197 15,736 12,719 12,357 17.20%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin -16.35 -122.60 -57.64 -17.90 55.14 -32.66 -43.40 -47.86%
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.03 -0.06 -0.08 -0.03 0.29 -0.05 -0.07 -43.18%
EPS Diluted -0.03 -0.06 -0.08 -0.02 0.21 -0.05 -0.07 -43.18%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.